| Baseline Characteristics |
N |
% |
| Patients enrolled |
32 |
|
| Age at enrollment, years
Mean
Range |
70
35-92 |
|
| Race/Ethnicity |
White |
100 |
| ECOG Performance Status
0
1
2
|
2
11
19
|
6
35
59
|
| Sites of metastatic disease
Bone only
Visceral with/without bone |
12
20 |
37
63 |
| Hormone receptor status
ER +/PR +
ER +/PR - |
25
7 |
78
22 |
| Histology
Lobular
Non-Lobular |
8
24 |
25
75 |
| Prior metastatic therapy (endocrine and non-endocrine)
Mean
Range |
2
2-6 |
|
|
Prior endocrine therapy (non-AI) |
25 |
78 |